Your browser doesn't support javascript.
loading
Discontinuation of tyrosine kinase inhibitors in pediatric chronic myeloid leukemia.
Shima, Haruko; Kada, Akiko; Tanizawa, Akihiko; Sato, Iori; Tono, Chikako; Ito, Masaki; Yuza, Yuki; Watanabe, Akihiro; Kamibeppu, Kiyoko; Uryu, Hideko; Koh, Katsuyoshi; Imai, Chihaya; Yoshida, Nao; Koga, Yuhki; Fujita, Naoto; Saito, Akiko M; Adachi, Souichi; Ishii, Eiichi; Shimada, Hiroyuki.
Afiliación
  • Shima H; Department of Pediatrics, Keio University School of Medicine, Tokyo, Japan.
  • Kada A; Clinical Research Center, National Hospital Organization Nagoya Medical Center, Aichi, Japan.
  • Tanizawa A; Sugita Genpaku Memorial Obama Municipal Hospital, Fukui, Japan.
  • Sato I; Department of Family Nursing, Division of Health Sciences and Nursing, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
  • Tono C; Department of Pediatrics, Iwate Prefectural Chubu Hospital, Iwate, Japan.
  • Ito M; Department of Pediatrics, Soma General Hospital, Fukushima, Japan.
  • Yuza Y; Department of Hematology/Oncology, Tokyo Metropolitan Children's Medical Center, Tokyo, Japan.
  • Watanabe A; Department of Pediatrics, Niigata Cancer Center Hospital, Niigata, Japan.
  • Kamibeppu K; Department of Family Nursing, Division of Health Sciences and Nursing, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
  • Uryu H; Department of Pediatrics, National Center for Global Health and Medicine, Tokyo, Japan.
  • Koh K; Department of Hematology/Oncology, Saitama Children's Medical Center, Saitama, Japan.
  • Imai C; Department of Pediatrics, Niigata University Graduate School of Medical and Dental Sciences, Niigata, Japan.
  • Yoshida N; Department of Hematology and Oncology, Children's Medical Center, Japanese Red Cross Nagoya First Hospital, Aichi, Japan.
  • Koga Y; Department of Pediatrics, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
  • Fujita N; Department of Pediatrics, Hiroshima Red Cross Hospital & Atomic-Bomb Survivors Hospital, Hiroshima, Japan.
  • Saito AM; Clinical Research Center, National Hospital Organization Nagoya Medical Center, Aichi, Japan.
  • Adachi S; Human Health Sciences, Kyoto University, Kyoto, Japan.
  • Ishii E; Department of Pediatrics, Ehime University Graduate School of Medicine, Ehime, Japan.
  • Shimada H; Department of Pediatrics, Keio University School of Medicine, Tokyo, Japan.
Pediatr Blood Cancer ; 69(8): e29699, 2022 08.
Article en En | MEDLINE | ID: mdl-35403816
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Leucemia Mielógena Crónica BCR-ABL Positiva / Leucemia Mieloide de Fase Crónica Tipo de estudio: Diagnostic_studies Límite: Child / Child, preschool / Humans Idioma: En Revista: Pediatr Blood Cancer Asunto de la revista: HEMATOLOGIA / NEOPLASIAS / PEDIATRIA Año: 2022 Tipo del documento: Article País de afiliación: Japón
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Leucemia Mielógena Crónica BCR-ABL Positiva / Leucemia Mieloide de Fase Crónica Tipo de estudio: Diagnostic_studies Límite: Child / Child, preschool / Humans Idioma: En Revista: Pediatr Blood Cancer Asunto de la revista: HEMATOLOGIA / NEOPLASIAS / PEDIATRIA Año: 2022 Tipo del documento: Article País de afiliación: Japón